search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
by research showing its efficacy and positive role in the con- text of nutribiosis. So how does it work?


Protease in action With the ability to cleave a peptide chain at almost any posi- tion, Axtra Pro ensures valuable amino acids are made availa- ble for muscle deposition and growth. Trials have shown it can improve the amino acid digestibility of feed ingredients by 12% in birds aged up to 21 days fed a corn/soybean meal diet, and by an average of 2.8% in broilers aged 25-34 days fed a corn/meat and bone meal diet. Significant digestibility improvements are recorded for all or most amino acids, even in the upper age range. This action reduces the level of undi- gested protein reaching the hind gut, which in turn means that less substrate is available for potentially non-beneficial bacteria. In this way, this protease indirectly inhibits the growth of non-beneficial microorganisms, as demonstrated by its application in a number of different commercial set- tings. In terms of C. perfringens, the addition of this consistent product to feed formulations results in a reduction in colony growth of 87% in broilers and 97% in turkeys. (Figure 1). While Avian Pathogenic E. Coli (APEC) populations have also been shown to be inhibited following supplementation with DuPont’s protease – recording a corresponding reduction of 93% and 96%, respectively.


Protease for a healthier gut With healthier conditions in the gut, less energy needs to be spent on fighting health challenges and it can instead be re- directed to support the performance of the bird. A positive outcome which delivers measurable performance benefits. One clear advantage is that production standards are main- tained, even under challenged conditions. This was demon- strated by a study carried out across two turkey farms, in


which the broad spectrum protease was used in the feed for- mulation for 12 weeks. During this period, one operation (Farm B) recorded an outbreak of cellulitis; a highly infectious, potentially fatal condition, that is most commonly caused by clostridial bacteria. In this challenged environment, those birds receiving feed supplemented with the product recorded a 12% improvement in liveability parameters. (Figure 2). So, although the use of protease cannot be said to directly affect liveability under normal circumstances – as demonstrated by the other (unchallenged) treatment group in the study – it is proven to be a valuable asset during unpredictable times of challenge. In addition, thanks to its ability to improve ener- getic efficiency, Axtra Pro supplementation has an equally positive impact on wider performance parameters; boosting both FCR and bodyweight gain.


Wider benefits Beyond the immediate concerns relating to gut health and performance, it is also worth noting that improving protein digestibility through protease supplementation helps to ad- dress the economic and environmental issues relating to the use of dietary protein in feed formulations. As protein is one of the most expensive nutrients in poultry diets, reducing the amount of crude protein in the formulation will automatically benefit the bottom line. Which means that by decreasing un- digested protein fractions, producers are able to achieve ami- no acid requirements with lower levels of crude protein, with- out compromising performance parameters. It also allows much greater flexibility in formulations by providing an effec- tive tool to deal with variability in raw materials. This allows the use of alternative, lower cost protein sources and reduces reliance on high cost soybean meals. Benefits which not only support commercial efficiency, but also help to ease increas- ing demand on natural resources.


▶ GUT HEALTH | DECEMBER 2020 41


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124